Literature DB >> 7715298

Indian kala-azar caused by Leishmania tropica.

D L Sacks1, R T Kenney, R D Kreutzer, C L Jaffe, A K Gupta, M C Sharma, S P Sinha, F A Neva, R Saran.   

Abstract

Kala-azar, or visceral leishmaniasis, in India is generally assumed to be a result of infection with Leishmania donovani. 15 parasite isolates collected over the past 10 years from patients with classical disease were typed by monoclonal antibodies, isoenzymes, and kDNA analysis. 4 were shown to be L tropica, a species historically associated with cutaneous disease and more recently a mild "visceralising" disease from the Desert Storm experience. The results confirm that L tropica is a co-endemic agent of visceral leishmaniasis in India, and may shed light on the rising frequency of therapeutic unresponsiveness to sodium antimony gluconate, which complicates treatment of this lethal disease.

Entities:  

Mesh:

Year:  1995        PMID: 7715298     DOI: 10.1016/s0140-6736(95)90703-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  33 in total

Review 1.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

2.  Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.

Authors:  S Mukhopadhyay; S Bhattacharyya; R Majhi; T De; K Naskar; S Majumdar; S Roy
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

3.  Molecular identification of an old clinical isolate of Indian Kala-azar.

Authors:  Madhumita Manna; Supriya Khanra
Journal:  J Parasit Dis       Date:  2016-06-04

4.  Human immune response to salivary proteins of wild-caught Phlebotomus papatasi.

Authors:  Rami M Mukbel; Rehab H Khasharmeh; Nawal S Hijjawi; Mohammed S Khalifeh; Ma'mon M Hatmal; Mary Ann McDowell
Journal:  Parasitol Res       Date:  2016-05-10       Impact factor: 2.289

5.  An axenic amastigote system for drug screening.

Authors:  H L Callahan; A C Portal; R Devereaux; M Grogl
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

Review 6.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

7.  Comparison of various sample preparation methods for PCR diagnosis of visceral leishmaniasis using peripheral blood.

Authors:  L Lachaud; E Chabbert; P Dubessay; J Reynes; J Lamothe; P Bastien
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

8.  Leishmania tropica in rock hyraxes (Procavia capensis) in a focus of human cutaneous leishmaniasis.

Authors:  Dalit Talmi-Frank; Charles L Jaffe; Abedelmajeed Nasereddin; Alon Warburg; Roni King; Milena Svobodova; Ofer Peleg; Gad Baneth
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

9.  Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay.

Authors:  Alexandra Schulz; Katja Mellenthin; Gabriele Schönian; Bernhard Fleischer; Christian Drosten
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

10.  Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis.

Authors:  Hamid Mahmoudzadeh-Niknam; Simin Sadat Kiaei; Davood Iravani
Journal:  Korean J Parasitol       Date:  2007-12       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.